輸入代號或公司名稱後按 Enter
6547

高端疫苗

-2.60 (-4.23%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
58.807,604成交張數本益比5.44股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.07-0.510.2219.4%0.63%-4.62%
2026Q1-0.09-0.89-0.28-26.8%-0.81%-7.93%
2025Q4-0.42-0.86-1.38-94.0%-3.90%-7.69%
2025Q3-0.07-0.50-0.23-11.0%-0.62%-4.44%
2025Q2-0.31-875.0%-0.43-1.00-69.0%-2.69%-3.77%
2025Q1-0.06-0.08-0.21-18.2%-0.55%-0.74%
2024Q4-0.06-0.24-0.22-17.2%-0.57%-2.09%
2024Q30.00-1.950.020.6%0.04%-15.48%
2024Q20.04-2.110.147.7%0.36%-16.64%
2024Q1-0.22-3.10-0.73-125.3%-1.93%-23.78%
2023Q4-1.77-3.53-5.82-339.8%-14.09%-26.14%
2023Q3-0.16-3.97-0.52-23.8%-1.17%-25.52%
2023Q2-0.95-4.06-3.14-6.73%-29.96%
2023Q1-0.65-4.76-2.12-4.31%-32.86%
2022Q4-2.21-165.6%-4.56-7.17-3022.0%-13.33%-30.39%
2022Q3-0.25-111.6%1.02-3.09-14768.8%-5.33%6.62%
2022Q2-1.653.43-3.08-2446.1%-5.89%29.72%
2022Q1-0.454.52-1.40-43.0%-3.03%37.45%
2021Q43.374.4610.6652.5%25.81%36.08%
2021Q32.160.466.8054.5%21.08%6.32%
2021Q2-0.57-2.39-1.79-19160.5%-6.07%-32.04%
2021Q1-0.50-2.43-1.57-4992.1%-5.09%-29.63%
2020Q4-0.64-2.42-1.87-2699.4%-8.23%-29.91%
2020Q3-0.69-2.61-1.83-6206.3%-12.47%-51.91%
2020Q2-0.61-2.45-1.73-15011.6%-10.69%-43.37%
2020Q1-0.49-2.51-1.31-27392.9%-8.58%-38.37%
2019Q4-0.82-2.60-1.91-39701.5%-14.79%-41.47%
2019Q3-0.52-2.46-1.26-9.94%-39.61%
2019Q2-0.67-2.32-1.62-25369.7%-11.54%-34.91%
2019Q1-0.58-1.39-8.95%
2018Q4-0.69-1.63-9.66%
2018Q3-0.38-0.93-5.11%
2018Q2-0.56-1.30